Choosing lipid lowering statin in risk strategy of cardiovascular event prevention

Aim. To investigate low density lipoprotein cholesterol (LDL-CH) lowering effectiveness of atorvastatin (Torvacard; 20 mg/d) in patients with moderate hypercholesterolemia (HCH) after 4 and 12 weeks of treatment, together with standard hypolipidemic diet; to assess (%) target LDL-CH level achievemen...

Disgrifiad llawn

Manylion Llyfryddiaeth

Prif Awduron:	A. Ya. Yvleva, L. A. Alekseeva, N. M. Poluboyarova
Fformat:	Artigo
Iaith:	Russo
Cyhoeddwyd:	«SILICEA-POLIGRAF» LLC 2007-02-01
Cyfres:	Кардиоваскулярная терапия и профилактика
Pynciau:	moderate hyperlipidemia statins atorvastatin (torvacard)
Mynediad Ar-lein:	https://cardiovascular.elpub.ru/jour/article/view/1144
Tagiau:	Ychwanegu Tag Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!